| POU2F1 antibodies | | | This is a review about POU2F1 antibodies, based on 8 published articles using POU2F1 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited POU2F1 antibody. |
| Santa Cruz Biotechnology search Santa Cruz Biotechnology POU2F1 products | | chip | Santa Cruz Biotechnology Oct-1 antibody was used in ChIP assay to study the association of human autoantigen La with pol III-transcribed genes in vivo. to the paper | | emsa | Santa Cruz monoclonal anti-Oct-1 antibody was used in EMSA to investigate the presence of a functional Oct-1 site within the human IFN-ß promoter sequence. to the paper | | wb | Santa Cruz Biotechnology anti-Oct-1 antibody was used in western blot to demonstrate that mutation of Cys105 inhibits dimerization of p12CDK2-AP1. to the paper | | wb | Santa Cruz Biotechnology antibody for Oct-1 was used in western blot to study the function of an atypical TNFR-associated factor-binding motif of BAFFR to mediate induction of the noncanonical NF-kappaB signaling pathway. to the paper | | chip, emsa, wb | Santa Cruz Biotechnologies rabbit anti-Oct-1 antibody was used in western blot, EMSA and ChIP assay to study the regulation of human 3' Igh hs4 enhancer activity in B cells by synergistic interaction between Oct-2 and NF-kappaB. to the paper | | wb | Santa Cruz Biotechnologies antibody against Oct-1 was used in western blot to investigate the oxidant-induced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor. to the paper | | ih | Santa Cruz Biotechnology polyclonal OCT-1 (sc-232) antibody was used in immunohistochemistry to study OCT-1, OCT-2, and BOB-1/OCA-B expression in normal lymphoid tissue and in T-cell neoplasms. to the paper | | ip, wb | Santa Cruz Biotechnology antibody against Oct-1 was used in western blot and immunoprecipitation to study the molecular mechanism by which BRCA1 regulates GADD45. to the paper |
| Articles Reviewed | | 1: | Martin Klar et al. Enhanceosome formation over the beta interferon promoter underlies a remote-control mechanism mediated by YY1 and YY2. 2005 | | 2: | Matthew D Morrison et al. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. 2005 | | 3: | Jennifer A Fairley et al. Human La is found at RNA polymerase III-transcribed genes in vivo. 2005 | | 4: | Yong Kim et al. Mutation of Cys105 inhibits dimerization of p12CDK2-AP1 and its growth suppressor effect. 2005 | | 5: | Manuel A Sepulveda et al. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. 2004 | | 6: | Congxiao Zhang et al. Oxidant-induced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor. 2003 | | 7: | Teresa Marafioti et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. 2003 | | 8: | Wenhong Fan et al. BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. 2002 |
|